Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
PALM BEACH, Fla., Dec. 23, 2020 /PRNewswire/ The cognitive assessment and training in healthcare market is positioned to have significant growth through the next several years. Cognitive assessment evaluates important areas of brain function. These areas include memory, concentration, processing speed, language, and reasoning capabilities. Cognitive assessments are critical to complete wellness because they have set a personalized benchmark of brain health for future comparison. A baseline cognitive assessment provides a reference point to measure against in case of problems or concerns (major illness or brain injury). Cognitive training or brain training is a tool, which can be utilized by educators and healthcare professionals to supplement and help enhance the therapeutic interactions with clients. A recent report said that the global cognitive assessment and training in healthcare market is f
Newswire & Press Release / Guardant Health AMEA Wins Frost & Sullivan s Market Leadership Award for Liquid Biopsy in Precision Oncology in - Pharma / BioTech / Nutrition - Frost & Sullivan
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.
Frost & Sullivan Honors Leading Organizations at its 2020 Best Practices Virtual Awards Ceremony
27 organizations recognized for their exemplary performance, growth, innovation and leadership across The Gulf Cooperation Council (GCC), India, Asia and North America
MUMBAI, India, Dec. 16, 2020 /PRNewswire/ Frost & Sullivan recognized leading organizations across The Gulf Cooperation Council (GCC), India, Asia and North America at its 2020 Best Practices Virtual Awards Ceremony on Dec. 15, 2020. Twenty-seven organizations were recognized for their visionary growth, innovation, leadership, commitment, customer service and successful business strategies required to advance in the global marketplace.
Photo - https://mma.prnewswire.com/media/1387177/2020 BP Awards Plaque.jpg
The awards were presented across the following sectors:
(2)
MUMBAI, India, Dec. 15, 2020 /PRNewswire/ Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan s 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company s flagship liquid biopsy, the Guardant360 test, which oncologists are using to guide treatment decisions for advanced stage cancer patients.
Photo - https://mma.prnewswire.com/media/1384995/Award Guardant Health.jpg
Guardant Health AMEA is breaking boundaries in advanced cancer diagnostics beyond invasive tissue biopsies, which are considered globally as the standard of care. Available in 41 countries across AMEA, the company s Guardant360 test provides quick and accurate comprehensive genomic profiling (CGP) information from a simple blood draw in seven days upon sample receipt in the laboratory.
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
- Five-year outcomes from large, prospective phase III ADAPT study confirm value of the test to help guide treatment decisions in breast cancer patients with high clinical risk, including those with node-positive disease
- New meta-analysis of data from more than 10,000 patients with node-negative disease, including the results of TAILORx, supports the Oncotype DX Breast Recurrence Score® test as the standard of care genomic test in early-stage, invasive breast cancer
News provided by
Share this article
MADISON, Wis., Dec. 11, 2020 /PRNewswire/
vimarsana © 2020. All Rights Reserved.